Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Other Accumulated Expenses (2018 - 2025)

Zai Lab's Other Accumulated Expenses history spans 8 years, with the latest figure at $63.7 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 8.45% year-over-year to $63.7 million; the TTM value through Dec 2025 reached $63.7 million, up 8.45%, while the annual FY2025 figure was $63.7 million, 8.45% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $63.7 million at Zai Lab, up from $51.5 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $83.0 million in Q4 2023 and bottomed at $36.8 million in Q1 2025.
  • The 5-year median for Other Accumulated Expenses is $54.0 million (2021), against an average of $55.1 million.
  • The largest annual shift saw Other Accumulated Expenses soared 101.39% in 2021 before it fell 29.23% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $60.8 million in 2021, then grew by 9.88% to $66.8 million in 2022, then increased by 24.18% to $83.0 million in 2023, then dropped by 29.23% to $58.7 million in 2024, then rose by 8.45% to $63.7 million in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's Other Accumulated Expenses are $63.7 million (Q4 2025), $51.5 million (Q3 2025), and $44.1 million (Q2 2025).